SpotitEarly
Englewood
About SpotitEarly
SpotitEarly offers a pre-screening test for various cancers using a single breath sample. This innovative approach allows individuals to conduct cancer screenings conveniently at home. The test accurately identifies four major cancer types: Breast, Lung, Colon, and Prostate. By simplifying the detection process, SpotitEarly aims to enhance early diagnosis, which is crucial for effective treatment. The company focuses on making cancer detection accessible and non-invasive, catering to the needs of patients and healthcare providers alike. Through its unique method, SpotitEarly contributes to advancing health management and early intervention strategies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $26.6M
- Last round: Grant (Dec 2025)
- Website: spotitearly.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Wellness
Social Profiles
Canonical: https://fsome.com/organization/spotitearly-112343 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.